6.46
price down icon3.44%   -0.23
after-market After Hours: 6.46
loading
Cvrx Inc stock is traded at $6.46, with a volume of 193.44K. It is down -3.44% in the last 24 hours and down -17.07% over the past month. CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
See More
Previous Close:
$6.69
Open:
$6.7
24h Volume:
193.44K
Relative Volume:
0.51
Market Cap:
$168.41M
Revenue:
$47.26M
Net Income/Loss:
$-58.48M
P/E Ratio:
-2.3883
EPS:
-2.7049
Net Cash Flow:
$-40.45M
1W Performance:
-5.00%
1M Performance:
-17.07%
6M Performance:
-51.79%
1Y Performance:
-25.66%
1-Day Range:
Value
$6.45
$6.7972
1-Week Range:
Value
$6.20
$6.95
52-Week Range:
Value
$4.2993
$18.55

Cvrx Inc Stock (CVRX) Company Profile

Name
Name
Cvrx Inc
Name
Phone
(763) 416-2850
Name
Address
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Name
Employee
206
Name
Twitter
Name
Next Earnings Date
2025-02-04
Name
Latest SEC Filings
Name
CVRX's Discussions on Twitter

Compare CVRX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
CVRX
Cvrx Inc
6.46 177.29M 47.26M -58.48M -40.45M -2.7049
Medical Devices icon
ABT
Abbott Laboratories
133.94 231.14B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
102.83 154.60B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
383.10 146.12B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
87.00 105.64B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
77.77 45.60B 5.54B 4.18B 623.10M 7.00

Cvrx Inc Stock (CVRX) Upgrades & Downgrades

Date Action Analyst Rating Change
May-09-25 Downgrade JP Morgan Neutral → Underweight
Jan-14-25 Upgrade William Blair Mkt Perform → Outperform
Sep-10-24 Initiated Cantor Fitzgerald Overweight
Jul-11-24 Reiterated Lake Street Buy
May-01-24 Resumed Craig Hallum Buy
May-01-24 Downgrade JP Morgan Overweight → Neutral
May-01-24 Downgrade William Blair Outperform → Mkt Perform
Jan-31-23 Initiated Lake Street Buy
Jul-18-22 Initiated Craig Hallum Buy
Jul-26-21 Initiated Canaccord Genuity Buy
Jul-26-21 Initiated Piper Sandler Overweight
Jul-26-21 Initiated William Blair Outperform
View All

Cvrx Inc Stock (CVRX) Latest News

pulisher
Jun 05, 2025

CVRx Confirms Directors and Accounting Firm at Meeting - TipRanks

Jun 05, 2025
pulisher
Jun 04, 2025

CVRx at William Blair Conference: Strategic Focus on Barostim - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

CVRx at William Blair Conference: Strategic Focus on Barostim By Investing.com - Investing.com UK

Jun 04, 2025
pulisher
Jun 04, 2025

Nuveen Asset Management LLC Has $2.01 Million Position in CVRx, Inc. (NASDAQ:CVRX) - Defense World

Jun 04, 2025
pulisher
Jun 01, 2025

Learn to Evaluate (CVRX) using the Charts - news.stocktradersdaily.com

Jun 01, 2025
pulisher
May 29, 2025

Millennium Management LLC Sells 30,168 Shares of CVRx, Inc. (NASDAQ:CVRX) - Defense World

May 29, 2025
pulisher
May 28, 2025

CVRx to Present at the William Blair 45th Annual Growth Stock Conference - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

Medical Device Leader CVRx Showcases Cardiovascular Breakthroughs at Major Growth Conference - Stock Titan

May 28, 2025
pulisher
May 27, 2025

CVRx, Inc. (NASDAQ:CVRX) Shares Acquired by Northern Trust Corp - Defense World

May 27, 2025
pulisher
May 26, 2025

D. E. Shaw & Co. Inc. Cuts Stock Position in CVRx, Inc. (NASDAQ:CVRX) - Defense World

May 26, 2025
pulisher
May 24, 2025

47,120 Shares in CVRx, Inc. (NASDAQ:CVRX) Purchased by BNP Paribas Financial Markets - Defense World

May 24, 2025
pulisher
May 21, 2025

Long Term Trading Analysis for (CVRX) - news.stocktradersdaily.com

May 21, 2025
pulisher
May 19, 2025

Monday 5/19 Insider Buying Report: HUM, CVRX - Nasdaq

May 19, 2025
pulisher
May 15, 2025

Director Makes Bold Move with Massive CVRx Stock Purchase - TipRanks

May 15, 2025
pulisher
May 14, 2025

CVRx Poised for Growth: Buy Rating Affirmed Amid Sales Restructuring and Potential Reimbursement Catalyst - TipRanks

May 14, 2025
pulisher
May 13, 2025

Insider Buying: Kevin Hykes Acquires Additional Shares of CVRx I - GuruFocus

May 13, 2025
pulisher
May 12, 2025

CVRx CEO Makes Bold Investment Move! - TipRanks

May 12, 2025
pulisher
May 12, 2025

Wells Fargo & Company MN Has $113,000 Holdings in CVRx, Inc. (NASDAQ:CVRX) - Defense World

May 12, 2025
pulisher
May 12, 2025

Barclays PLC Boosts Stake in CVRx, Inc. (NASDAQ:CVRX) - Defense World

May 12, 2025
pulisher
May 11, 2025

(CVRX) Trading Advice - news.stocktradersdaily.com

May 11, 2025
pulisher
May 11, 2025

Piper Sandler Has Lowered Expectations for CVRx (NASDAQ:CVRX) Stock Price - Defense World

May 11, 2025
pulisher
May 11, 2025

CVRx, Inc. (NASDAQ:CVRX) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World

May 11, 2025
pulisher
May 11, 2025

CVRx Reports First Quarter 2025 Financial and Operating Results - ADVFN

May 11, 2025
pulisher
May 10, 2025

CVRx, Inc. (NASDAQ:CVRX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025
pulisher
May 10, 2025

JPMorgan cuts CVRx stock rating, slashes price target to $7 By Investing.com - Investing.com India

May 10, 2025
pulisher
May 09, 2025

CVRx (CVRX) Sees Downgrade and Price Target Reduction from JP Mo - GuruFocus

May 09, 2025
pulisher
May 09, 2025

CVRx (CVRX) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 09, 2025
pulisher
May 09, 2025

CVRx Earnings Call: Growth Amidst Challenges - TipRanks

May 09, 2025
pulisher
May 09, 2025

CVRx (CVRX) Shares Fall Following Q1 Sales Miss and Downgrade - GuruFocus

May 09, 2025
pulisher
May 09, 2025

CVRx price target lowered to $12 from $20 at Piper Sandler - TipRanks

May 09, 2025
pulisher
May 09, 2025

JPMorgan cuts CVRx stock rating, slashes price target to $7 - Investing.com

May 09, 2025
pulisher
May 09, 2025

CVRx stock downgraded at J.P. Morgan on Q1 miss (CVRX:NASDAQ) - Seeking Alpha

May 09, 2025
pulisher
May 09, 2025

Demystifying CVRx: Insights From 4 Analyst Reviews - Benzinga

May 09, 2025
pulisher
May 09, 2025

CVRx (CVRX) Target Price Lowered by Piper Sandler | CVRX Stock N - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Analysts Offer Insights on Healthcare Companies: VYNE Therapeutics (VYNE) and CVRx (CVRX) - The Globe and Mail

May 09, 2025
pulisher
May 09, 2025

Investors Appear Satisfied With CVRx, Inc.'s (NASDAQ:CVRX) Prospects As Shares Rocket 25% - simplywall.st

May 09, 2025
pulisher
May 09, 2025

This National Vision Holdings Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday - Benzinga

May 09, 2025
pulisher
May 09, 2025

This International Paper Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - Benzinga

May 09, 2025
pulisher
May 09, 2025

JPMorgan Downgrades CVRx to Underweight From Neutral, Adjusts Price Target to $7 From $15 - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

Dave To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga

May 09, 2025
pulisher
May 09, 2025

CVRx Q1 2025 revenue increases 15% to USD 12.3 million - Medical Buyer

May 09, 2025
pulisher
May 09, 2025

CVRx: Q1 Earnings Snapshot - San Francisco Chronicle

May 09, 2025
pulisher
May 09, 2025

CVRx downgraded to Underweight from Neutral at JPMorgan - TipRanks

May 09, 2025
pulisher
May 09, 2025

CVRx Q1 2025 Earnings Call Transcript - MarketBeat

May 09, 2025
pulisher
May 09, 2025

Earnings call transcript: CVRx Q1 2025 shows improved EPS, stock dips - Investing.com Nigeria

May 09, 2025
pulisher
May 09, 2025

CVRx Inc (CVRX) Q1 2025 Earnings Call Highlights: Revenue Growth Amid Sales Force Realignment ... By GuruFocus - Investing.com Canada

May 09, 2025
pulisher
May 08, 2025

CVRx Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 08, 2025

Cvrx Inc Stock (CVRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Cvrx Inc Stock (CVRX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Nielsen Kirk G.
Director
May 13 '25
Buy
5.29
101,413
536,313
1,837,968
Nielsen Kirk G.
Director
May 14 '25
Buy
5.23
61,200
320,364
1,899,168
Nielsen Kirk G.
Director
May 12 '25
Buy
4.79
25,200
120,670
1,736,555
Jain Mudit K.
Director
May 12 '25
Buy
4.66
1,500
6,986
4,900
Jain Mudit K.
Director
May 13 '25
Buy
5.26
150
789
5,050
Hykes Kevin
PRES & CEO
May 12 '25
Buy
4.84
5,000
24,200
133,000
$317.16
price down icon 0.64%
medical_devices STE
$243.58
price up icon 0.61%
medical_devices SNN
$30.30
price up icon 3.52%
$71.55
price up icon 0.59%
$85.74
price up icon 0.15%
medical_devices EW
$77.77
price down icon 0.10%
Cap:     |  Volume (24h):